Both semaglutide and tirzepatide are effective for weight loss, but studies show that tirzepatide (Mounjaro, Zepbound, etc) generally causes more weight loss than semaglutide (Ozempic, Wegovy, etc) due to its added GIP receptor activity in addition to GLP1
A: Occasionally, mild cases linked to a temporary cause (like pregnancy) improve on their own
Polyphenols and other bioactive compounds found in plant foods have been studied for potential effects on GLP-1 secretion through various mechanisms, including modulation of gut microbiota composition and, in laboratory studies, inhibition of DPP-4
Introducing the medication at a low dose allows your body to slowly adapt to its presence and effects
any changes must be guided by a clinician based on accurate blood pressure readings and a full clinical review, in line with NICE guideline NG136
And because we now understand some of those genetic drivers and that this can be a disease for folks, it takes that away